BREDA, the Netherlands and GHENT, Belgium, September 12, 2013 /PRNewswire/ --
Breakthrough data to be presented during the 'Discovery on Target' conference in Boston, MA, USA on September 23, 2013
arGEN-X, a clinical stage human monoclonal antibody therapeutics company, announces it......
More...
